This approach addresses inconsistencies found in previous studies [20, 22, 23, 25] and offers a comprehensive evaluation of Ang-II stimulating AHMs in reducing the risk of dementia or MCI, representing a significant and novel contribution to the field. The gene discussed is AGT; the disease is dementia.